Target intelligence / Profile preview

Phosphotriesterase (PTE)

Target
PTE
Molecular classification
Enzyme, Hydrolase, Metalloenzyme, Member of the amidohydrolase superfamily
01

Overview

Phosphotriesterase is an enzyme found in certain soil bacteria (notably Pseudomonas diminuta and Flavobacterium species) that catalyzes the hydrolysis of organophosphate triesters, which include a wide range of toxic pesticides and chemical warfare agents such as sarin and paraoxon. The enzyme features a (β/α)₈ TIM-barrel protein fold with a binuclear metal active site—typically zinc—that is essential for its catalytic activity. Notably, PTE has an extremely broad substrate specificity and can hydrolyze various synthetic organophosphates at rates approaching the diffusion limit, though it does not have a known natural physiological substrate. Due to its role in rapidly detoxifying neurotoxic organophosphates, PTE has been extensively studied as a candidate for bioremediation and as a bioscavenger to protect against poisoning and nerve agent exposure. Directed evolution and protein engineering have produced variants with enhanced activity and specificity for particular organophosphate substrates relevant to defense and public health applications.

Other names
AryldialkylphosphataseOrganophosphate hydrolaseOpdA (specific ortholog from Agrobacterium radiobacter)Organophosphate degrading enzyme
02

Mechanism of action

Catalyzes hydrolysis of phosphorus-oxygen or phosphorus-fluorine bonds in organophosphates, converting toxic compounds to non-toxic metabolites. Metal-ion-assisted nucleophilic substitution (often via two Zn²⁺ ions at the active site).

03

Biological functions

Detoxification of organophosphorus compoundsHydrolysis of organophosphate triesters and phosphorofluoridatesEnvironmental bioremediation
04

Disease associations

Infection (indirectly relevant in context of nerve agent and pesticide poisoning)Other (detoxification of neurotoxic organophosphates; public/biodefense relevance rather than classical disease roles)
05

Safety considerations

No specific safety concerns identified for PTE itself as a therapeutic; use in humans is experimentalPotential immunogenicity or delivery challenges if used as a therapeutic enzymeOff-target hydrolysis of endogenous organophosphates could be a theoretical risk
06

Interacting drugs

Paraoxon (substrate, not a classical drug, but an organophosphate pesticide)

2 more in the full profile.

07

Biomarkers

None established for patient selection or efficacy monitoring in clinical useHydrolysis products (e.g., p-nitrophenol, diethyl phosphoric acid) as possible research biomarkers for enzyme activityPotential surrogate markers of detoxification in laboratory or environmental monitoring

Beyond the preview

Go deeper on Phosphotriesterase (PTE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphotriesterase (PTE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call